Cell and Gene Logistics
-
Transitioning From Using RUO To cGMP Chemicals For Clinical Trials
10/17/2023
Learn about the common challenges and risks associated with accelerating your molecule's timeline from lab to clinic, along with important supply chain considerations for emerging biopharma companies.
-
Supporting Bench To Production Applications For Multiple Industries
10/17/2023
Grow and scale up your manufacturing with the right support, and choose from 92,000+ chemicals provided through an extensive global network of 3,500+ manufacturers.
-
Essential Guide To Cell And Gene Therapy Commercialization
10/10/2023
After devoting time, expertise, and financial resources to developing a transformative cell or gene therapy, it is essential to ensure patients can receive all of the benefits of your innovation.
-
Improving Access And Support For Cell And Gene Therapies
10/9/2023
Although cell and gene therapies (CGTs) are potentially transformative, their effectiveness is undermined by difficulties with patient access and support, high costs, and a complex pathway to treatment.
-
Future Challenges And Predictions For CGT Patient-Focused Solutions
10/4/2023
Leveraging innovative technologies to predict, model, and analyze data will enhance resource allocation, improve patient experience, reduce timelines, and drive cost efficiencies in the CGT industry.
-
FDA Announces 1-Year “Stabilization” Period For DSCSA Compliance — Don’t Mistake It For An Enforcement Delay
10/4/2023
On August 30 in a new guidance document, the FDA announced the establishment of a one-year stabilization period with regard to the enhanced security and unit-level electronic traceability requirements of the Drug Supply Chain Security Act (DSCSA) that go into effect on Nov. 27, 2023. The FDA makes it clear that this is not an opportunity to delay implementation; rather, it is an opportunity to refine, improve, and stabilize your systems and processes.
-
3 Questions To Ask When Building A CGT Commercialization Strategy
10/3/2023
Learn how aligning with the right partner and leveraging integrated solutions gives access to crucial know-how and ensures the patient receives the most seamless, accessible treatment option available.
-
CGT Solutions Brochure
9/30/2023
Leveraging a partner with expertise and integrated, end-to-end solutions can help overcome obstacles to increase patient access and ensure the safe distribution of your advanced therapy product.
-
Cell & Gene Therapy Solutions
9/29/2023
Your therapy can make all the difference. Together, we’ll unlock its potential.
-
How Innovations In Cryologistics Support Patient Access To CGTs
9/28/2023
Understanding the infrastructure required to fulfill the CGT demands and finding the right partner to meet these demands are crucial components for delivering quality products and expanding CGT access.